- Home
- INMB vs PHUN Comparison
INMB vs PHUN Comparison
Compare INMB & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMB | PHUN |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 38.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | INMB | PHUN |
|---|---|---|
| Price | $1.44 | $1.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.30 | ★ $7.25 |
| AVG Volume (30 Days) | ★ 332.6K | 220.2K |
| Earning Date | 03-26-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $50,000.00 | ★ $2,357,000.00 |
| Revenue This Year | $264.29 | N/A |
| Revenue Next Year | N/A | $95.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.05 | N/A |
| 52 Week Low | $1.38 | $1.56 |
| 52 Week High | $11.64 | $4.03 |
Technical Indicators
Market Signals| Indicator | INMB | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 45.49 |
| Support Level | $1.44 | $1.56 |
| Resistance Level | $1.67 | $2.02 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 12.82 | 48.35 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.